 high-dos chemotherapi reinfus autolog bone marrow dose-intens induct initi therapi metastat breast cancer toxic efficaci high-dos chemotherapi consolid reinfus autolog bone marrow women metastat breast cancer dose-intens outpati regimen thirti women hormone-unrespons metastat breast cancer adjuv doxorubicin chemotherapi metastat diseas cyclophosphamid methotrex doxorubicin fluorouracil vincristin leucovorin week patient complet respons partial respons patient next phase protocol ie marrow harvest treatment cyclophosphamid thiotepa day marrow micrograms/ml patient predomin side effect myelosuppress gastrointestin death toxic effect patient partial respons outpati phase treatment complet respons high-dos therapi partial respons patient complet respons site bone median time progress patient studi month median surviv month origin patient diseas progress median month entri studi studi dose-intens regimen use purg marrow accept toxic profil approach result high respons rate women metastat breast cancer basi regimen high-risk adjuv set